Feasibility of imaging of epidermal growth factor receptor expression with ZEGFR:2377 affibody molecule labeled with 99mTc using a peptide-based cysteine-containing chelator.
about
Preparation and Identification of HER2 Radioactive Ligands and Imaging Study of Breast Cancer-Bearing Nude Mice.Affibody molecules as engineered protein drugs.Comparative evaluation of tumor targeting using the anti-HER2 ADAPT scaffold protein labeled at the C-terminus with indium-111 or technetium-99m.Cyclic versus Noncyclic Chelating Scaffold for 89Zr-Labeled ZEGFR:2377 Affibody Bioconjugates Targeting Epidermal Growth Factor Receptor Overexpression.Preclinical Evaluation of [Ga]Ga-DFO-ZEGFR:2377: A Promising Affibody-Based Probe for Noninvasive PET Imaging of EGFR Expression in Tumors
P2860
Feasibility of imaging of epidermal growth factor receptor expression with ZEGFR:2377 affibody molecule labeled with 99mTc using a peptide-based cysteine-containing chelator.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 October 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Feasibility of imaging of epid ...... cysteine-containing chelator.
@en
Feasibility of imaging of epid ...... cysteine-containing chelator.
@nl
type
label
Feasibility of imaging of epid ...... cysteine-containing chelator.
@en
Feasibility of imaging of epid ...... cysteine-containing chelator.
@nl
prefLabel
Feasibility of imaging of epid ...... cysteine-containing chelator.
@en
Feasibility of imaging of epid ...... cysteine-containing chelator.
@nl
P2860
P50
P356
P1476
Feasibility of imaging of epid ...... d cysteine-containing chelator
@en
P2093
Ken G Andersson
Stefan Ståhl
P2860
P304
P356
10.3892/IJO.2016.3721
P577
2016-10-05T00:00:00Z